Investors

Press Releases

All Releases

View Summary Regeneron to Report Third Quarter 2015 Financial and Operating Results and Host Conference Call and Webcast on November 4, 2015
Oct 8, 2015
PDF 8.2 KB Add to Briefcase
View Summary Regeneron and Sanofi Announce Publication of Positive Phase 2b Dupilumab Data in The Lancet
Oct 8, 2015
PDF 17.5 KB Add to Briefcase
View Summary Regeneron Announces Collaboration with Mitsubishi Tanabe Pharma for Investigational Pain Therapy Fasinumab in Asia
Oct 1, 2015
PDF 14.1 KB Add to Briefcase
View Summary Regeneron and Sanofi Announce Approval of Praluent® (alirocumab) for the Treatment of Hypercholesterolemia in the European Union
Sep 28, 2015
PDF 24.5 KB Add to Briefcase
View Summary Regeneron and Icahn School of Medicine at Mount Sinai Announce New Antibody Research Agreement
Sep 24, 2015
PDF 16.9 KB Add to Briefcase
View Summary Regeneron Announces Agreement with BARDA for the Development of New Antibody Treatment for Ebola
Sep 21, 2015
PDF 12.9 KB Add to Briefcase
View Summary Regeneron Hires Maya Bermingham as Executive Director, Public Policy
Sep 10, 2015
PDF 6.9 KB Add to Briefcase
View Summary Regeneron Discovery on Cause of Rare Genetic Bone Disease Detailed in Science Translational Medicine Publication
Sep 2, 2015
PDF 11.9 KB Add to Briefcase
View Summary Regeneron and Sanofi Announce New Positive Praluent® (alirocumab) Phase 3 Data Presented at ESC Congress 2015
Sep 1, 2015
PDF 25.4 KB Add to Briefcase
View Summary Regeneron Announces Upcoming 2015 Investor Conference Presentations
Aug 31, 2015
PDF 7.9 KB Add to Briefcase
View Summary Regeneron Reports Second Quarter 2015 Financial and Operating Results
Aug 4, 2015
PDF 38.2 KB Add to Briefcase
View Summary Regeneron and Sanofi Launch Major New Immuno-Oncology Collaboration
Jul 28, 2015
PDF 20.9 KB Add to Briefcase
View Summary Regeneron and Sanofi Announce FDA Approval of Praluent® (alirocumab) Injection, the First PCSK9 Inhibitor in the U.S., for the Treatment of High LDL Cholesterol in Adult Patients
Jul 24, 2015
PDF 26.1 KB Add to Briefcase
View Summary Regeneron and Sanofi Announce CHMP Recommends European Approval of Praluent® (alirocumab) for the Treatment of Hypercholesterolemia
Jul 24, 2015
PDF 18.1 KB Add to Briefcase
View Summary Regeneron and Sanofi Announce Phase 3 Results Showing LDL-C Reductions of More Than 60 Percent in Japanese Patients Treated with Praluent® (alirocumab) Injection
Jul 8, 2015
PDF 19.2 KB Add to Briefcase
View Summary Regeneron to Report Second Quarter 2015 Financial and Operating Results and Host Conference Call and Webcast on August 4, 2015
Jul 8, 2015
PDF 8.2 KB Add to Briefcase
View Summary New Film Documents Heart Felt Stories of People Living with High LDL Cholesterol
Jun 30, 2015
PDF 14.3 KB Add to Briefcase
View Summary Regeneron Rapid Response Platform for Emerging Infectious Diseases Described in Proceedings of the National Academy of Sciences Publication
Jun 29, 2015
PDF 13.0 KB Add to Briefcase
View Summary EYLEA® (aflibercept) Injection Receives Approval in Japan for the Treatment of Retinal Vein Occlusion
Jun 26, 2015
PDF 16.5 KB Add to Briefcase
View Summary Regeneron Announces 2015 Winners of the Regeneron Prize for Creative Innovation
Jun 25, 2015
PDF 8.5 KB Add to Briefcase
Showing 21-40 of 312 Page: 1 2 3 4 5 6 ... 16  Previous 20 | Next 20
Add to Briefcase = add release to Briefcase


Close
Form content here please :)